Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy
Epilepsy Behav. 2026 Apr 14;180:111036. doi: 10.1016/j.yebeh.2026.111036. Online ahead of print.NO ABSTRACTPMID:41985207 | DOI:10.1016/j.yebeh.2026.111036
